Assessment of Liver Diseases Using a Deep-Learning Approach Based on Ultrasound RF-Data
LivSPECTRUS
Acquisition and Frequency Spectroscopic Evaluation of Broadband Clinical Ultrasound Raw Data for Liver Cirrhosis and Focal Pathologies Using Neural Networks for Tissue and Pathology Differentiation
1 other identifier
interventional
200
1 country
4
Brief Summary
The goal of this clinical trial is to test the performance of neuronal networks trained on ultrasonic raw Data (=radiofrequency data) for the assessment of liver diseases in patients undergoing a clinical ultrasound examination. The general feasibility is currently evaluated in a retrospective cohort. The main questions the study aims to answer are:
- Can a neuronal network trained on RF Data perform equally good as elastography in the assessment of diffuse liver diseases?
- Can a neuronal network trained on RF Data perform better than a neuronal network trained on b-mode images in the assessment of diffuse liver diseases?
- Can a neuronal network trained on RF Data distinguish focal pathologies in the liver from healthy tissue? To answer these questions participants with a clinically indicated fibroscan will undergo:
- a clinical elastography in Case ob suspected diffuse liver disease
- a reliable ground truth (if normal ultrasound is not sufficient e.g. contrast enhanced ultrasound, biopsy, MRI or CT) in case of focal liver diseases, depending on the standard routine of the participating center
- a clinical ultrasound examination during which b-mode images and the corresponding RF-Data sets are captured
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2024
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 1, 2024
CompletedFirst Posted
Study publicly available on registry
March 19, 2024
CompletedStudy Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedAugust 20, 2025
August 1, 2025
1.5 years
March 1, 2024
August 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Performance analysis of the trained model
Analysis of the concordance of a Deep Learning-based analysis of RF data with established clinical measures. In case of diffuse disease the stiffness of the tissue and in case of the focal lesions the underlying disease as diagnosed by the local physicians are the measures. Performance is evaluated by the area under the receiver operating characteristic curve and a correlation coefficient.
After study completion, estimated 1 year
Study Arms (2)
Elastography
EXPERIMENTALCollection of ultrasound data and elastography data from patients who were clinically planned for elastography
Focal lesion
EXPERIMENTALCollection of ultrasound data of the suspected lesion and a definitive diagnosis based on either normal ultrasound investigation or if not sufficient additional investigations like CEUS, Biopsy, MRI or CT. This further investigation should be in accordance to normal clinical routine of the centers to differentiate focal lesions.
Interventions
patients who are scheduled for an elastography for clinical reasons usually receive an ultrasound scan in which the b-mode images of the liver tissue are collected. In this study additional radiofrequency data is collected through a software access.
Patients who are transferred to the ultrasound departement due to suspicious focal lesions receive an ultrasonic investigation including the acquisition of raw data and extracting a definitive diagnose from the following clinical routine investigation, depending on the standards of the participating center
Eligibility Criteria
You may qualify if:
- scheduled for an ultrasound investigation by an independent physician
- signed declaration of consent
You may not qualify if:
- smaller interventions in the same liver during the last 2 Week (for example liver biopsy)
- contrast enhanced ultrasound less than a day ago
- major intervention at the liver (for example partial resection)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Technische Universität Dresdenlead
- University Hospital Dresdencollaborator
- University of Leipzigcollaborator
Study Sites (4)
University Hospital
Dresden, 01307, Germany
Diakonissen Hospital Dresden
Dresden, Germany
University Hospital Halle (Saale)
Halle, Germany
University Hospital Leipzig
Leipzig, Germany
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Moritz Herzog, MD
University Hospital Dresden
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 1, 2024
First Posted
March 19, 2024
Study Start
April 1, 2024
Primary Completion
October 1, 2025
Study Completion
December 1, 2025
Last Updated
August 20, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- after finishing the study, data will be stored locally for at least 7 years
- Access Criteria
- contact the investigators via mail
After the publication of data the anonymized IPD will be provided.